Publicaciones en colaboración con investigadores/as de University of Massachusetts Medical School (7)

2024

  1. AI is a viable alternative to high throughput screening: a 318-target study

    Scientific Reports, Vol. 14, Núm. 1

  2. Correction to: AI is a viable alternative to high throughput screening: a 318-target study (Scientific Reports, (2024), 14, 1, (7526), 10.1038/s41598-024-54655-z)

    Scientific Reports

2022

  1. Activation of the unfolded protein response (Upr) is associated with cholangiocellular injury, fibrosis and carcinogenesis in an experimental model of fibropolycystic liver disease

    Cancers, Vol. 14, Núm. 1

2021

  1. Myeloid Endoplasmic Reticulum Resident Chaperone GP96 Facilitates Inflammation and Steatosis in Alcohol-Associated Liver Disease

    Hepatology Communications, Vol. 5, Núm. 7, pp. 1165-1182

2020

  1. Inhibition of HSP90 and Activation of HSF1 Diminish Macrophage NLRP3 Inflammasome Activity in Alcohol-Associated Liver Injury

    Alcoholism: Clinical and Experimental Research, Vol. 44, Núm. 6, pp. 1300-1311

  2. Loss of c-Jun N-terminal Kinase 1 and 2 Function in Liver Epithelial Cells Triggers Biliary Hyperproliferation Resembling Cholangiocarcinoma

    Hepatology Communications, Vol. 4, Núm. 6, pp. 834-851

2002

  1. Power of outcome measurements to detect clinically significant changes in pulmonary rehabilitation of patients with COPD

    Chest, Vol. 121, Núm. 4, pp. 1092-1098